Evidence map›Paper›PMID 37209125›Full record

ArticleEuropean radiology2023

Deep learning for detection of iso-dense, obscure masses in mammographically dense breasts.

Krithika Rangarajan, Pranjal Aggarwal, Dhruv Kumar Gupta, Rohan Dhanakshirur, Akhil Baby, Chandan Pal, Arun Kumar Gupta, Smriti Hari, Subhashis Banerjee, Chetan Arora

Erratum issuedAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Krithika RangarajanAll India Institute of Medical Sciences, Ansari Nagar New Delhi, 110029, India. krithikarangarajan86@gmail.com.ORCID http://orcid.org/0000-0001-5376-6390
Pranjal AggarwalIndian Institute of Technology, Delhi, Hauz Khas, Delhi, 110016, India.
Dhruv Kumar GuptaIndian Institute of Technology, Delhi, Hauz Khas, Delhi, 110016, India.
Rohan DhanakshirurIndian Institute of Technology, Delhi, Hauz Khas, Delhi, 110016, India.
Akhil BabyAll India Institute of Medical Sciences, Ansari Nagar New Delhi, 110029, India.
Chandan PalAll India Institute of Medical Sciences, Ansari Nagar New Delhi, 110029, India.
Arun Kumar GuptaAll India Institute of Medical Sciences, Ansari Nagar New Delhi, 110029, India.
Smriti HariAll India Institute of Medical Sciences, Ansari Nagar New Delhi, 110029, India.
Subhashis BanerjeeIndian Institute of Technology, Delhi, Hauz Khas, Delhi, 110016, India.
Chetan AroraIndian Institute of Technology, Delhi, Hauz Khas, Delhi, 110016, India.
All India Institute of Medical Sciences · INIndian Institute of Technology Delhi · IN

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR33193/AI/133/5/2019
6 · The paper itself

Abstract

objectivesTo analyze the performance of deep learning in isodense/obscure masses in dense breasts. To build and validate a deep learning (DL) model using core radiology principles and analyze its performance in isodense/obscure masses. To show performance on screening mammography as well as diagnostic mammography distribution.

methodsThis was a retrospective, single-institution, multi-centre study with external validation. For model building, we took a 3-pronged approach. First, we explicitly taught the network to learn features other than density differences: such as spiculations and architectural distortion. Second, we used the opposite breast to enable the detection of asymmetries. Third, we systematically enhanced each image by piece-wise-linear transformation. We tested the network on a diagnostic mammography dataset (2569 images with 243 cancers, January to June 2018) and a screening mammography dataset (2146 images with 59 cancers, patient recruitment from January to April 2021) from a different centre (external validation).

resultsWhen trained with our proposed technique (and compared with baseline network), sensitivity for malignancy increased from 82.7 to 84.7% at 0.2 False positives per image (FPI) in the diagnostic mammography dataset, 67.9 to 73.8% in the subset of patients with dense breasts, 74.6 to 85.3 in the subset of patients with isodense/obscure cancers and 84.9 to 88.7 in an external validation test set with a screening mammography distribution. We showed that our sensitivity exceeded currently reported values (0.90 at 0.2 FPI) on a public benchmark dataset (INBreast).

conclusionModelling traditional mammographic teaching into a DL framework can help improve cancer detection accuracy in dense breasts. CLINICAL RELEVANCE STATEMENT: Incorporating medical knowledge into neural network design can help us overcome some limitations associated with specific modalities. In this paper, we show how one such deep neural network can help improve performance on mammographically dense breasts. KEY POINTS: • Although state-of-the-art deep learning networks achieve good results in cancer detection in mammography in general, isodense, obscure masses and mammographically dense breasts posed a challenge to deep learning networks. • Collaborative network design and incorporation of traditional radiology teaching into the deep learning approach helped mitigate the problem. • The accuracy of deep learning networks may be translatable to different patient distributions. We showed the results of our network on screening as well as diagnostic mammography datasets.

Indexed as

Breast NeoplasmsDeep LearningBreast DensityEarly Detection of CancerFemaleHumansMammographyRetrospective StudiesArtificial intelligenceDeep learningMammography

Identifiers

PMID37209125
OpenAlexW4377139545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.